+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Biopharmaceuticals Market Research Reports

From
From
From
From
Microbiome Therapeutics Global Market Report 2022 - Product Thumbnail Image

Microbiome Therapeutics Global Market Report 2022

  • Report
  • September 2022
  • 175 Pages
  • Global
From
Multivalent Vaccines Market 2024 - Product Thumbnail Image

Multivalent Vaccines Market 2024

  • Report
  • December 2024
  • 175 Pages
  • Global
From
From
Vaccines Global Market Opportunities And Strategies To 2031 - Product Thumbnail Image

Vaccines Global Market Opportunities And Strategies To 2031

  • Report
  • January 2023
  • 343 Pages
  • Global
From
From
From
From
FLUAD QUADRIVALENT Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

FLUAD QUADRIVALENT Drug Insight and Market Forecast - 2032

  • Report
  • November 2023
  • 30 Pages
  • Global
From
FLUCELVAX QUADRIVALENT Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

FLUCELVAX QUADRIVALENT Drug Insight and Market Forecast - 2032

  • Report
  • November 2023
  • 30 Pages
  • Global
From
From
From
Microbiome - Competitive Landscape, 2026 - Product Thumbnail Image

Microbiome - Competitive Landscape, 2026

  • Report
  • January 2026
  • 550 Pages
  • Global
From
Cancer Vaccines - Competitive Landscape, 2026 - Product Thumbnail Image

Cancer Vaccines - Competitive Landscape, 2026

  • Report
  • January 2026
  • 500 Pages
  • Global
From
Monoclonal Antibodies - Competitive Landscape, 2026 - Product Thumbnail Image

Monoclonal Antibodies - Competitive Landscape, 2026

  • Report
  • January 2026
  • 450 Pages
  • Global
From
Etanercept - Biosimilar Insight, 2024 - Product Thumbnail Image

Etanercept - Biosimilar Insight, 2024

  • Report
  • August 2024
  • 60 Pages
  • Global
From
From
Loading Indicator

The biopharmaceuticals market is a sector of the pharmaceutical industry that focuses on the development and production of drugs derived from biological sources. These drugs are typically produced using recombinant DNA technology, which involves the manipulation of genetic material to create proteins and other molecules with therapeutic properties. Biopharmaceuticals are used to treat a wide range of diseases, including cancer, HIV/AIDS, and autoimmune disorders. Biopharmaceuticals are typically more expensive to produce than traditional pharmaceuticals, but they offer a number of advantages, such as improved efficacy and fewer side effects. They are also more targeted, meaning they can be used to treat specific conditions more effectively. Some of the major companies in the biopharmaceuticals market include Amgen, Biogen, Celgene, Gilead Sciences, and Novartis. These companies are involved in the development and production of a wide range of biopharmaceuticals, including monoclonal antibodies, vaccines, and gene therapies. Show Less Read more